Hanrahan Jessie 4

What Happened

• Jessie Hanrahan, Chief Regulatory Officer of Solid Biosciences (SLDB), sold 12,348 shares on 2026-02-04. The weighted-average sale price was $6.44 per share, generating approximately $79,545 in proceeds. This was a sale (not a purchase) and appears to be routine sell-to-cover activity rather than a discretionary market-timing trade.

Key Details

• Transaction date: February 4, 2026; Form 4 filed February 6, 2026 (timely filing).
• Sale type/code: S (sale) — sell-to-cover to satisfy tax withholding after RSU vesting.
• Price: weighted average $6.44; actual trades executed across a range of $6.28 to $6.60.
• Proceeds: ~$79,545.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes: The sale was effected under a durable automatic sell-to-cover instruction adopted by Dr. Hanrahan on August 16, 2024 and was not a discretionary trade. The filing notes the weighted-average price and offers to provide a breakdown of shares sold at each price on request.

Context

• This was a tax-withholding sale following the vesting of restricted stock units (RSUs). Such sell-to-cover transactions are common and typically reflect withholding requirements rather than a statement about the insider’s view on the company’s stock.